18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT

Iman Khodarahmi, Roger E. Turbin, Larry P. Frohman, Nasrin Ghesani

Research output: Contribution to journalArticle


While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque.

Original languageEnglish (US)
Pages (from-to)e410-e411
JournalClinical nuclear medicine
Issue number9
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of '18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT'. Together they form a unique fingerprint.

  • Cite this

    Khodarahmi, I., Turbin, R. E., Frohman, L. P., & Ghesani, N. (2016). 18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT. Clinical nuclear medicine, 41(9), e410-e411. https://doi.org/10.1097/RLU.0000000000001284